Literature DB >> 32295905

Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.

Carolina Scagnolari1,2, Fabiana Cannella3,2, Alessandra Pierangeli3,2, Rebecca Mellinger Pilgrim4, Guido Antonelli3,2, Dayana Rowley5, Margaret Wong6, Simon Best4, Deyin Xing6, Richard B S Roden6, Raphael Viscidi7.   

Abstract

We demonstrate that female C57BL/6J mice are susceptible to a transient lower genital tract infection with MmuPV1 mouse papillomavirus and display focal histopathological abnormalities resembling those of human papillomavirus (HPV) infection. We took advantage of strains of genetically deficient mice to study in vivo the role of innate immune signaling in the control of papillomavirus. At 4 months, we sacrificed MmuPV1-infected mice and measured viral 757/3139 spliced transcripts by TaqMan reverse transcription-PCR (RT-PCR), localization of infection by RNAscope in situ hybridization, and histopathological abnormities by hematoxylin and eosin (H&E) staining. Among mice deficient in receptors for pathogen-associated molecular patterns, MyD88-/- and STING-/- mice had 1,350 and 80 copies of spliced transcripts/μg RNA, respectively, while no viral expression was detected in MAVS-/- and Ripk2-/- mice. Mice deficient in an adaptor molecule, STAT1-/-, for interferon signaling had 46,000 copies/μg RNA. Among mice with targeted deficiencies in the inflammatory response, interleukin-1 receptor knockout (IL-1R-/-) and caspase-1-/- mice had 350 and 30 copies/μg RNA, respectively. Among mice deficient in chemokine receptors, CCR6-/- mice had 120 copies/μg RNA, while CXCR2-/- and CXCR3-/- mice were negative. RNAscope confirmed focal infection in MyD88-/-, STAT1-/-, and CCR6-/- mice but was negative for other gene-deficient mice. Histological abnormalities were seen only in the latter mice. Our findings and the literature support a working model of innate immunity to papillomaviruses involving the activation of a MyD88-dependent pathway and IL-1 receptor signaling, control of viral replication by interferon-stimulated genes, and clearance of virus-transformed dysplastic cells by the action of the CCR6/CCL20 axis.IMPORTANCE Papillomaviruses infect stratified squamous epithelia, and the viral life cycle is linked to epithelial differentiation. Additionally, changes occur in viral and host gene expression, and immune cells are activated to modulate the infectious process. In vitro studies with keratinocytes cannot fully model the complex viral and host responses and do not reflect the contribution of local and migrating immune cells. We show that female C57BL/6J mice are susceptible to a transient papillomavirus cervicovaginal infection, and mice deficient in select genes involved in innate immune responses are susceptible to persistent infection with variable manifestations of histopathological abnormalities. The results of our studies support a working model of innate immunity to papillomaviruses, and the model provides a framework for more in-depth studies. A better understanding of mechanisms of early viral clearance and the development of approaches to induce clearance will be important for cancer prevention and the treatment of HPV-related diseases.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  innate immunity; papillomaviruses

Year:  2020        PMID: 32295905      PMCID: PMC7307098          DOI: 10.1128/JVI.00087-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.

Authors:  M Nees; J M Geoghegan; T Hyman; S Frank; L Miller; C D Woodworth
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.

Authors:  B Jiang; M Xue
Journal:  Genet Mol Res       Date:  2015-09-08

3.  High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.

Authors:  Jeanette Reiser; José Hurst; Maike Voges; Peter Krauss; Peter Münch; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

Review 4.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

Review 5.  Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.

Authors:  C J de Witte; A J M van de Sande; H J van Beekhuizen; M M Koeneman; A J Kruse; C G Gerestein
Journal:  Gynecol Oncol       Date:  2015-08-31       Impact factor: 5.482

6.  The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.

Authors:  Cindy Chiang; Eva-Katharina Pauli; Jennifer Biryukov; Katharina F Feister; Melissa Meng; Elizabeth A White; Karl Münger; Peter M Howley; Craig Meyers; Michaela U Gack
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 7.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

8.  Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas.

Authors:  John P Sundberg; Timothy M Stearns; Joongho Joh; Mary Proctor; Arvind Ingle; Kathleen A Silva; Soheil S Dadras; A Bennett Jenson; Shin-je Ghim
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

9.  Isolation of three novel rat and mouse papillomaviruses and their genomic characterization.

Authors:  Eric Schulz; Marc Gottschling; Rainer G Ulrich; Dania Richter; Eggert Stockfleth; Ingo Nindl
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

Review 10.  The Role of Chemokines in Wound Healing.

Authors:  Anisyah Ridiandries; Joanne T M Tan; Christina A Bursill
Journal:  Int J Mol Sci       Date:  2018-10-18       Impact factor: 5.923

View more
  7 in total

1.  Passive Immunization with a Single Monoclonal Neutralizing Antibody Protects against Cutaneous and Mucosal Mouse Papillomavirus Infections.

Authors:  Sarah A Brendle; Jingwei Li; Nancy M Cladel; Karla K Balogh; Jennifer Booth; Debra A Shearer; Vonn Walter; Song Lu; Neil D Christensen; Danielle Covington; Jake DeBroff; Janice Milici; Yusheng Zhu; Raphael Viscidi; Jiafen Hu
Journal:  J Virol       Date:  2022-08-03       Impact factor: 6.549

2.  Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model.

Authors:  Jiafen Hu; Sarah A Brendle; Jingwei J Li; Vonn Walter; Nancy M Cladel; Timothy Cooper; Debra A Shearer; Karla K Balogh; Neil D Christensen
Journal:  Viruses       Date:  2022-05-06       Impact factor: 5.818

3.  A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using Mus musculus Papillomavirus.

Authors:  Renee E King; Andrea Bilger; Josef Rademacher; Ella T Ward-Shaw; Rong Hu; Paul F Lambert; Susan L Thibeault
Journal:  Viruses       Date:  2022-05-08       Impact factor: 5.818

4.  A prognostic value of CD45RA+, CD45RO+, CCL20+ and CCR6+ expressing cells as 'immunoscore' to predict cervical cancer induced by HPV.

Authors:  Ana Teresa G Fernandes; Maria Odete O Carvalho; Elyzabeth Avvad-Portari; Natália P Rocha; Fabio Russomano; Eric Henrique Roma; Maria da Gloria Bonecini-Almeida
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

Review 5.  The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity.

Authors:  Ya Wang; Xiaoli Wang; Meiling Zhu; Li Ge; Xiaochen Liu; Kaikai Su; Zhengzheng Chen; Weidong Zhao
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

6.  Detection of Equus Caballus Papillomavirus Type-2 in Asymptomatic Italian Horses.

Authors:  Katia Cappelli; Chiara Grazia De Ciucis; Samanta Mecocci; Tiziana Nervo; Maria Ines Crescio; Marco Pepe; Rodolfo Gialletti; Daniele Pietrucci; Laura Federica Migone; Silvia Turco; Luca Mechelli; Fabrizio Passamonti; Carlo Drago; Gian Guido Donato; Katia Varello; Paola Modesto; Giovanni Chillemi; Alessandro Ghelardi; Elisabetta Razzuoli
Journal:  Viruses       Date:  2022-07-31       Impact factor: 5.818

Review 7.  Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway.

Authors:  Isabelle Meyts; Jean-Laurent Casanova
Journal:  Eur J Immunol       Date:  2021-04-04       Impact factor: 5.532

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.